Asia-Pacific Neurological Biomarkers Market Report 2018

Asia-Pacific Neurological Biomarkers Market Report 2018

Jan 2018 QYResearch Biomarkers156 Pages Price :
$ 4000

This report studies the Neurological Biomarkers Market status and outlook of Asia-Pacific and major countries, from angles of players, regions, product types and end industries; this report analyzes the top players in Asia-Pacific and major countries, and splits the Neurological Biomarkers Market by product type and applications/end industries.


In the last several years, Asia Pacific market of Neurological Biomarkers developed rapidly, with an average growth rate of 21.4%. In 2017, Asia Pacific revenue of Neurological Biomarkers is nearly 360 M USD.


The major players in Asia Pacific Neurological Biomarkers market include
Thermo Fisher
Merck
Bio-Rad Laboratories
Roche
QIAGEN
Athena Diagnostics
Myriad RBM
Cisbio Bioassays
Wuxi APP
BGI
Aepodia
Genewiz
Proteome Sciences


Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Neurological Biomarkers in these regions, from 2013 to 2024 (forecast), covering
Japan
China
India
Korea
Southeast Asia
Australia
RoAP


On the basis of product, the Neurological Biomarkers market is primarily split into
Proteomics
Genomics
Imaging
Bioinformatics
Others


On the basis on the end users/applications, this report covers
Diagnostics
Drug Discovery
Personalized Medicine
Others



 

Table of Contents

1 Neurological Biomarkers Overview1
1.1 Product Overview and Scope of Neurological Biomarkers1
1.2 Classification of Neurological Biomarkers by Product Category3
1.2.1 Asia-Pacific Neurological Biomarkers Revenue Comparison by Types (2013-2024)3
1.2.2 Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 20174
1.2.3 Genomics5
1.2.4 Proteomics5
1.2.5 Imaging6
1.2.6 Bioinformatics6
1.3 Asia-Pacific Neurological Biomarkers Market by Applications/End Users7
1.3.1 Asia-Pacific Neurological Biomarkers Revenue and Market Share Comparison by Applications (2013-2024)7
1.3.2 Drug Discovery8
1.3.3 Diagnostics9
1.3.4 Personalized Medicine10
1.4 Asia-Pacific Neurological Biomarkers Market by Regions11
1.4.1 Asia-Pacific Neurological Biomarkers Revenue Comparison by Regions (2013-2024)11
1.4.2 China Neurological Biomarkers Status and Prospect (2013-2024)12
1.4.3 Japan Neurological Biomarkers Status and Prospect (2013-2024)13
1.4.4 Korea Neurological Biomarkers Status and Prospect (2013-2024)14
1.4.5 India Neurological Biomarkers Status and Prospect (2013-2024)15
1.4.6 Southeast Asia Neurological Biomarkers Status and Prospect (2013-2024)16
1.4.7 Australia Neurological Biomarkers Status and Prospect (2013-2024)17
1.4.8 RoAP Neurological Biomarkers Status and Prospect (2013-2024)18
1.5 Asia-Pacific Revenue and Revenue of Neurological Biomarkers (2013-2024)19
2 Asia-Pacific Neurological Biomarkers Competition by Players/Manufacturers, Type and Application20
2.1 Asia-Pacific Neurological Biomarkers Market Competition by Players/Manufacturers20
2.2 Asia-Pacific Neurological Biomarkers Revenue and Revenue by Type22
2.3 Asia-Pacific Neurological Biomarkers Revenue and Revenue by Regions24
2.4 Asia-Pacific Neurological Biomarkers Revenue by Application26
3 China Neurological Biomarkers Revenue Analysis29
3.1 China Neurological Biomarkers Revenue and Market Share (2013-2018)29
3.2 China Neurological Biomarkers Revenue and Market Share by Type29
3.3 China Neurological Biomarkers Revenue and Market Share by Applications31
4 Japan Neurological Biomarkers Revenue Analysis33
4.1 Japan Neurological Biomarkers Revenue and Market Share (2013-2018)33
4.2 Japan Neurological Biomarkers Revenue and Market Share by Type34
4.3 Japan Neurological Biomarkers Revenue and Market Share by Applications35
5 Korea Neurological Biomarkers Revenue Analysis37
5.1 Korea Neurological Biomarkers Revenue and Market Share (2013-2018)37
5.2 Korea Neurological Biomarkers Revenue and Market Share by Type37
5.3 Korea Neurological Biomarkers Revenue and Market Share by Applications39
6 India Neurological Biomarkers Revenue Analysis41
6.1 India Neurological Biomarkers Revenue and Market Share (2013-2018)41
6.2 India Neurological Biomarkers Revenue and Market Share by Type41
6.3 India Neurological Biomarkers Revenue and Market Share by Applications43
7 Australia Neurological Biomarkers Revenue Analysis45
7.1 Australia Neurological Biomarkers Revenue and Market Share (2013-2018)45
7.2 Australia Neurological Biomarkers Revenue and Market Share by Type46
7.3 Australia Neurological Biomarkers Revenue and Market Share by Applications47
8 Southeast Asia Neurological Biomarkers Revenue Analysis49
8.1 Southeast Asia Neurological Biomarkers Revenue and Market Share (2013-2018)49
8.2 Southeast Asia Neurological Biomarkers Revenue and Market Share by Type49
8.3 Southeast Asia Neurological Biomarkers Revenue and Market Share by Applications51
9 RoAP Neurological Biomarkers Revenue Analysis53
9.1 RoAP Neurological Biomarkers Revenue and Market Share (2013-2018)53
9.2 RoAP Neurological Biomarkers Revenue and Market Share by Type54
9.3 RoAP Neurological Biomarkers Revenue and Market Share by Applications55
10 Analysis of Neurological Biomarkers Industry Key Manufacturers57
10.1 Thermo Fisher57
10.1.1 Company Profile57
10.1.2 Product Information59
10.1.3 Revenue, Cost, Gross and Gross Margin60
10.2 Merck60
10.2.1 Company Profile60
10.2.2 Product Information61
10.2.3 Revenue, Cost, Gross and Gross Margin61
10.3 Bio-Rad Laboratories62
10.3.1 Company Profile62
10.3.2 Product Information63
10.3.3 Revenue, Cost, Gross and Gross Margin64
10.4 Roche64
10.4.1 Company Profile64
10.4.2 Product Information66
10.4.3 Revenue, Cost, Gross and Gross Margin66
10.5 QIAGEN67
10.5.1 Company Profile67
10.5.2 Product Information68
10.5.3 Revenue, Cost, Gross and Gross Margin69
10.6 Athena Diagnostics69
10.6.1 Company Profile69
10.6.2 Product Information70
10.6.3 Revenue, Cost, Gross and Gross Margin71
10.7 Myriad RBM71
10.7.1 Company Profile71
10.7.2 Product Information72
10.7.3 Revenue, Cost, Gross and Gross Margin73
10.8 Cisbio Bioassays74
10.8.1 Company Profile74
10.8.2 Product Information75
10.8.3 Revenue, Cost, Gross and Gross Margin75
10.9 Wuxi APP76
10.9.1 Company Profile76
10.9.2 Product Information77
10.9.3 Revenue, Cost, Gross and Gross Margin77
10.10 BGI78
10.10.1 Company Profile78
10.10.2 Product Information79
10.10.3 Revenue, Cost, Gross and Gross Margin79
10.11 Aepodia79
10.11.1 Company Profile79
10.11.2 Product Information80
10.11.3 Revenue, Cost, Gross and Gross Margin81
10.12 Genewiz81
10.12.1 Company Profile81
10.12.2 Product Information82
10.12.3 Revenue, Cost, Gross and Gross Margin82
10.13 Proteome Sciences83
10.13.1 Company Profile83
10.13.2 Product Information84
10.13.3 Revenue, Cost, Gross and Gross Margin84
11 Neurological Biomarkers as Cost Analysis85
11.1 Drug Development R&D Cost Analysis85
11.1.1 Clinical Phase Costs86
11.1.2 Capitalized Costs87
11.2 Proportion of Manufacturing Cost Structure88
11.2.1 Raw Materials88
11.2.2 Labor Cost89
11.2.2.1 USA Labor Cost Analysis89
11.2.2.2 Europe Labor Costs Analysis91
11.2.2.3 Asia Labor Costs Analysis93
11.2.3 Other Costs Analysis95
11.2.3.1 USA Other Cost Analysis95
11.2.3.2 Europe Other Cost Analysis96
11.2.3.3 China Other Cost Analysis97
11.3 Manufacturing Process Analysis of Neurological Biomarkers99
12 Industrial Chain, Sourcing Strategy and Downstream Buyers100
12.1 Neurological Biomarkers Industrial Chain Analysis100
12.2 Upstream Raw Materials Sourcing101
12.3 Downstream Buyers101
13 Marketing Strategy Analysis, Distributors/Traders103
13.1 Marketing Channel103
13.1.1 Direct Marketing103
13.1.2 Indirect Marketing103
13.1.3 Marketing Channel Development Trend103
13.2 Market Positioning104
13.2.1 Market Positioning104
13.2.2 Brand Strategy105
13.2.2.1 Introducing pharmaceutical branding strategies105
13.2.2.2 Building pharmaceutical brands106
13.2.2.3 Communicating pharmaceutical brands106
13.2.2.4 Alternative brand models107
13.2.2.5 The future of pharmaceutical branding108
13.3 Distributors/Traders List108
14 Market Effect Factors Analysis111
14.1 Technology Progress/Risk111
14.1.1 Biomarker Development Pipeline111
14.1.2 Technologies Progress of Biomarker112
14.2 Consumer Needs/Customer Preference Change115
14.3 Economic/Political Environmental Change116
15 Asia-Pacific Neurological Biomarkers Market Forecast (2018-2024)123
15.1 Asia-Pacific Neurological Biomarkers Revenue Forecast (2018-2024)123
15.2 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2018-2024)124
15.2.1 Asia-Pacific Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2018-2024)124
15.2.2 China Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)126
15.2.3 Korea Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)127
15.2.4 Japan Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)128
15.2.5 India Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)129
15.2.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)130
15.2.7 Australia Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)131
15.2.8 RoAP Neurological Biomarkers Revenue and Growth Rate Forecast (2018-2024)132
15.3 Asia-Pacific Neurological Biomarkers Revenue and Price Forecast by Type (2018-2024)132
15.4 Asia-Pacific Neurological Biomarkers Revenue Forecast by Application (2018-2024)133
16 Research Findings and Conclusion135
17 Methodology and Data Source136
17.1 Methodology/Research Approach136
17.1.1 Research Programs/Design136
17.1.2 Market Size Estimation137
17.1.3 Market Breakdown and Data Triangulation138
17.2 Data Source139
17.2.1 Secondary Sources139
17.2.2 Primary Sources140
17.3 Disclaimer141
17.4 Author List142
 

List of Table

List of Tables and Figures

Figure Product Picture of Neurological Biomarkers2
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Comparison by Types (2013-2024)3
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Types in 20174
Figure Genomics Product Picture5
Figure Proteomics Product Picture5
Figure Imaging Product Picture6
Figure Bioinformatics Product Picture6
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Comparison by Applications (2013-2024)7
Figure Asia-Pacific Revenue Market Share of Neurological Biomarkers by Applications in 20178
Figure Drug Discovery Examples8
Figure Diagnostics Examples9
Figure Personalized Medicine Examples10
Table Asia-Pacific Market Neurological Biomarkers Revenue (M USD) Comparison by Regions 2013-202411
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)12
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)13
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)14
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)15
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)16
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)17
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)18
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2024)19
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Players/Manufacturers (2016-2017)20
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers (2016-2017)20
Figure 2016 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers21
Figure 2017 Asia-Pacific Neurological Biomarkers Revenue Market Share by Players/Manufacturers22
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Type (2013-2018)22
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Type (2013-2018)23
Figure Revenue Market Share of Neurological Biomarkers by Type (2013-2018)23
Figure Asia-Pacific Neurological Biomarkers Revenue Growth Rate by Type in 201724
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Regions (2013-2018)24
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions (2013-2018)25
Figure Revenue Market Share of Neurological Biomarkers by Regions (2013-2018)25
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions in 201726
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) by Application (2013-2018)26
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)27
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application (2013-2018)27
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Application in 201728
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)29
Table China Neurological Biomarkers Revenue (M USD) by Type (2013-2018)29
Table China Neurological Biomarkers Revenue Market Share by Type (2013-2018)30
Figure China Neurological Biomarkers Revenue Market Share by Type in 201730
Table China Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)31
Table China Neurological Biomarkers Revenue Market Share by Applications (2013-2018)31
Figure China Neurological Biomarkers Revenue Market Share by Applications in 201732
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)33
Table Japan Neurological Biomarkers Revenue (M USD) by Type (2013-2018)34
Table Japan Neurological Biomarkers Revenue Market Share by Type (2013-2018)34
Figure Japan Neurological Biomarkers Revenue Market Share by Type in 201735
Table Japan Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)35
Table Japan Neurological Biomarkers Revenue Market Share by Applications (2013-2018)36
Figure Japan Neurological Biomarkers Revenue Market Share by Applications in 201736
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)37
Table Korea Neurological Biomarkers Revenue (M USD) by Type (2013-2018)37
Table Korea Neurological Biomarkers Revenue Market Share by Type (2013-2018)38
Figure Korea Neurological Biomarkers Revenue Market Share by Type in 201738
Table Korea Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)39
Table Korea Neurological Biomarkers Revenue Market Share by Applications (2013-2018)39
Figure Korea Neurological Biomarkers Revenue Market Share by Applications in 201740
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)41
Table India Neurological Biomarkers Revenue (M USD) by Type (2013-2018)41
Table India Neurological Biomarkers Revenue Market Share by Type (2013-2018)42
Figure India Neurological Biomarkers Revenue Market Share by Type in 201742
Table India Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)43
Table India Neurological Biomarkers Revenue Market Share by Applications (2013-2018)43
Figure India Neurological Biomarkers Revenue Market Share by Applications in 201744
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)45
Table Australia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)46
Table Australia Neurological Biomarkers Revenue Market Share by Type (2013-2018)46
Figure Australia Neurological Biomarkers Revenue Market Share by Type in 201747
Table Australia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)47
Table Australia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)48
Figure Australia Neurological Biomarkers Revenue Market Share by Applications in 201748
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)49
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Type (2013-2018)49
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Type (2013-2018)50
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Type in 201750
Table Southeast Asia Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)51
Table Southeast Asia Neurological Biomarkers Revenue Market Share by Applications (2013-2018)51
Figure Southeast Asia Neurological Biomarkers Revenue Market Share by Applications in 201752
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate (2013-2018)53
Table RoAP Neurological Biomarkers Revenue (M USD) by Type (2013-2018)54
Table RoAP Neurological Biomarkers Revenue Market Share by Type (2013-2018)54
Figure RoAP Neurological Biomarkers Revenue Market Share by Type in 201755
Table RoAP Neurological Biomarkers Revenue (M USD) by Applications (2013-2018)55
Table RoAP Neurological Biomarkers Revenue Market Share by Applications (2013-2018)55
Figure RoAP Neurological Biomarkers Revenue Market Share by Applications in 201756
Table Thermo Fisher Company Profile57
Figure Neurological Biomarkers Product Picture and Specifications of Thermo Fisher59
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Thermo Fisher 2016-201760
Table Merck Company Profile60
Figure Neurological Biomarkers Product Picture and Specifications of Merck61
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck 2016-201761
Table Bio-Rad Laboratories Company Profile62
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bio-Rad Laboratories 2016-201764
Table Roche Company Profile64
Table Neurological Biomarkers Product Picture and Specifications of Roche66
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2016-201766
Table QIAGEN Company Profile67
Table Neurological Biomarkers Product Picture and Specifications of QIAGEN68
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of QIAGEN 2016-201769
Table Athena Diagnostics Company Profile69
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Athena Diagnostics 2016-201771
Table Myriad RBM Company Profile71
Figure Neurological Biomarkers Product Picture and Specifications of Myriad RBM73
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Myriad RBM 2016-201773
Table Cisbio Bioassays Company Profile74
Figure Neurological Biomarkers Product Picture and Specifications of Cisbio Bioassays75
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Cisbio Bioassays 2016-201775
Table Wuxi APP Company Profile76
Table Neurological Biomarkers Product Picture and Specifications of Wuxi APP77
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Wuxi APP 2016-201777
Table BGI Company Profile78
Table Neurological Biomarkers Product Picture and Specifications of BGI79
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of BGI 2016-201779
Table Aepodia Company Profile79
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Aepodia 2016-201781
Table Genewiz Company Profile81
Table Neurological Biomarkers Product Picture and Specifications of Genewiz82
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Genewiz 2016-201782
Table Proteome Sciences Company Profile83
Table Neurological Biomarkers Product Picture and Specifications of Proteome Sciences84
Table Neurological Biomarkers Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Proteome Sciences 2016-201784
Figure typical phases from research to the market for a drug candidate86
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound87
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound88
Figure Manufacturing Cost Structure of Neurological Biomarkers88
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour)89
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)89
Figure Cost of Employing a Factory Worker91
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe92
Figure Monthly Minimum Wages in Asia 201693
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year)94
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month)94
Table Average Price of Electricity to Ultimate Customers95
Figure Electricity Prices for Household Consumers in 201696
Figure Summary of the Driving Assumptions97
Figure Industrial Electric Rates 2016 (PER KWH)98
Figure Manufacturing Process Analysis of Neurological Biomarkers99
Figure Neurological Biomarkers Industrial Chain Analysis100
Table Major Buyers of Neurological Biomarkers101
Table Distributors/Traders List108
Figure Biomarker Development Pipeline111
Figure Shotgun Proteomics For Biomarker Candidate Discovery113
Figure Spectral Counting113
Figure Targeted Quantitative Analyses of Biomarker Candidates114
Figure Antibody Development for Biomarker Candidates115
Figure Global GDP Growth Rate for 2016117
Figure Japan GDP 2006-2016 (Billion USD)118
Figure Japan CPI Change 2012-2016118
Figure China GDP 2006-2016 (Billion USD)119
Figure China CPI Change 2016-2017119
Figure Korea GDP 2006-2016 (Billion USD)120
Figure Korea CPI Change 2017120
Figure India GDP 2006-2016 (Billion USD)120
Figure India CPI Change 2017121
Figure Australia GDP 2006-2016 (Billion USD)121
Figure Australia CPI Change 2015-2017121
Figure Taiwan GDP 2006-2016 (Billion USD)122
Figure Taiwan CPI Change 2017122
Figure Asia-Pacific Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)123
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Regions (2018-2024)124
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions (2018-2024)124
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Regions in 2023125
Figure China Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)126
Figure Korea Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)127
Figure Japan Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)128
Figure India Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)129
Figure Southeast Asia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)130
Figure Australia Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)131
Figure RoAP Neurological Biomarkers Revenue (M USD) and Growth Rate Forecast (2018-2024)132
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Type (2018-2024)132
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Type (2018-2024)133
Table Asia-Pacific Neurological Biomarkers Revenue (M USD) Forecast by Application (2018-2024)133
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share Forecast by Application (2018-2024)134
Table Research Programs/Design for This Report136
Figure Bottom-up and Top-down Approaches for This Report138
Figure Data Triangulation139
Table Key Data Information from Secondary Sources140
Table Key Data Information from Primary Sources141

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 4000
$ 8000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top